IRIS International, Inc. (IRIS)l to Present NADiA ProsVue at Two Important Meetings in Washington DC Addressing the Role of Advanced Diagnostics in Cancer

9/20/2012 9:56:37 AM

CHATSWORTH, Calif., Sept. 20, 2012 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables, and a provider of high value personalized medicine solutions today announced that IRIS has received the honor of being asked to speak at two upcoming important meetings: AdvaMedDx's Hill Briefing on "The Role of Advanced Diagnostics in Cancer Care" and the Eighth Annual Summit of the Prostate Health Education Network, Inc.

Read at GlobeNewswire

Read Article at

Related Companies

News Categories

• GlobeNewswire

• IRIS International, Inc.

• Medical Devices

• Medical Dev. & Diag. - Events